At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Cutera enlighten laser +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal
In Brief
A clinical study evaluating Cutera enlighten laser and CynoSure PicoSure 755nm laser for Tattoo Removal. Completed, enrolled 11 participants across 1 site.
Detailed Summary
Study to evaluate safety and efficacy of treatment with the investigational Cutera enlighten laser for tattoo removal as compared to treatment with the Cynosure PicoSure laser
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTattoo Removal
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedSep 2016
Primary CompletionAug 2017
TodayJul 2026
First PostedSep 23, 2016
Enrollment StartSep 9, 2016
Primary CompletionAug 16, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.8 years ago
Interventions
Cutera enlighten laserdevice
high-powered, Q-switched 670nm Picosecond laser system indicated for tattoo removal
CynoSure PicoSure 755nm laserdevice
high-powered, Q-switched Alexandrite system that delivers laser energy in the 755 nm wavelength and has received FDA clearance (K133364) for tattoo and benign pigmented lesion removal.